Alcon to obtain U.S. The product is currently in clinical development to take care of dry eye and various other ocular surface diseases.S. Osher, MD, professor of ophthalmology at the University of Cincinnati College of Medicine and medical director emeritus of the Cincinnati Eye Institute. SOURCE Alcon.However, the bone mineral density of the patients at baseline was around 10 percent below the mean value for youthful adult females, and the bone mineral density in individuals receiving placebo reduced by 3 to 4 percent at the spine, femoral throat, and trochanter through the trial. This total result indicates that these women were having postmenopausal bone loss. 3 Women who experienced disorders of mineral and bone fat burning capacity, smoked more than 20 cigarettes each day, or consumed three or more alcoholic drinks per day were excluded.